Director Leonidas C. Platanias works at the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics, USA.

• 1. Contemporary Management of Dermatofibrosarcoma Protuberans2. Management of Locoregional Melanoma3. Current Management of Intraductal Papillary Mucinous Neoplasms4. Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy5. Optimal Front-Line Therapy for Non[1]Oncogene-Driven Non-Small Cell Lung Cancer6. Beyond First-Line Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKI): Approach to Resistance7. Antibody-Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application8. Surgery for Recurrent Ovarian Cancer9. Big Data in Pediatric Oncology: Hope, Hype, Reality10. Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas11. Diagnostic and Theranostic Opportunities in Neuro-Oncology12. Updates on Revised Diagnostic Criteria and Targeted Therapies for Neurofibromatosis13. Management of Relapsed Refractory Large B[1]Cell Non-Hodgkin Lymphoma: Chimeric Antigen Receptor T-Cell Therapy versus Autologous Stem Cell Transplantation14. T-cell Acute Lymphoblastic Leukemia: Novel Therapies Worth Watching15. Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia16. Role of Circulating Tumor DNA for Monitoring of Recurrence and Treatment Response in Urothelial Cancer17. Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: 18. Patient Selection and Overview of Doublet and Triplet Therapy Data19. Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions20. Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers21. Current and Emerging Therapeutic Options for Human Epidermal Growth Factor Receptor 2-Expressing Gastroesophageal Cancers22. Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma23. Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma